ATOS

ATOS

USD

Atossa Therapeutics Inc. Common Stock

$0.878-0.008 (-0.903%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.886

Haut

$0.934

Bas

$0.870

Volume

0.52M

Fondamentaux de l'Entreprise

Capitalisation Boursière

113.4M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.69M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.55Actuel $0.878Haut $1.66

Actualités Connexes

Analyst Upgrades

Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5

Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7.25 to $7.5.

Voir plus
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5
Analyst Upgrades

Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4

Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Therapeutics with a Buy rating and announces Price Target of $4.

Voir plus
Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4
PR Newswire

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for...

Voir plus
Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.